Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.
Rahul BanerjeeBo WangLarry D AndersonGeorgia McCaughanNikita MehraAndrew J CowanSundararajan Vincent RajkumarGurbakhash KaurPublished in: Blood cancer journal (2023)